Tenet Healthcare COO sells 24,000 company shares

Rhea-AI Filing Summary

TENET HEALTHCARE CORP (THC) executive Lisa Y. Foo, EVP and Chief Operating Officer, reported selling 24,000 shares of common stock on August 31, 2026, in an open-market transaction at a weighted average price of $266.32 per share. After these sales, she directly holds 8,053 shares of Tenet Healthcare common stock. The shares were sold in multiple trades at prices ranging from $266.02 to $266.95 per share.

Insider Trade Summary

Net Seller: 24,000 shares

Net Sell 1 txn

Insider Foo Lisa Y

Role EVP, Chief Operating Officer

Sold 24,000 shs ($6.39M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	24,000	$266.32	$6.39M

Holdings After Transaction: Common Stock — 8,053 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $266.02 to $266.95. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 24,000 shares of Common Stock Weighted average price: $266.32 per share Price range of sales: $266.02–$266.95 per share +1 more

4 metrics

Shares sold 24,000 shares of Common Stock Non-derivative sale on August 31, 2026

Weighted average price $266.32 per share Weighted average sales price for the 24,000 shares sold

Price range of sales $266.02–$266.95 per share Range of prices for multiple transactions included in the sale

Shares owned after transaction 8,053 shares of Common Stock Direct ownership following the reported sale

Key Terms

weighted average sales price, open market or private transaction, non-derivative

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate"

open market or private transaction financial

"Sale in open market or private transaction"

non-derivative financial

""transaction_type": "non-derivative""

FAQ

What insider transaction did THC report for executive Lisa Y. Foo?

Lisa Y. Foo reported a sale of 24,000 shares of Tenet Healthcare common stock on August 31, 2026, executed as an open-market or private transaction at a weighted average price of $266.32 per share.

At what prices were Lisa Y. Foo’s THC shares sold?

The 24,000 shares sold by Lisa Y. Foo were executed in multiple transactions at prices ranging from $266.02 to $266.95 per share, with a weighted average sales price of $266.32 per share.

How many THC shares does Lisa Y. Foo hold after the reported sale?

After selling 24,000 shares of Tenet Healthcare common stock, Lisa Y. Foo directly holds 8,053 shares of THC common stock.

Was the THC insider sale by Lisa Y. Foo part of a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmed for this transaction, and the related footnote does not state that the sale was made pursuant to a Rule 10b5-1 trading plan.

What role does Lisa Y. Foo hold at THC in this Form 4 filing?

Lisa Y. Foo is identified as an officer of Tenet Healthcare, serving as EVP, Chief Operating Officer in the Form 4 filing reporting this transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 08:00 PM Accepted by SEC EDGAR 09/01/2026 - 08:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foo Lisa Y

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		S		24,000	D	$266.32(1)	8,053	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $266.02 to $266.95. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener, as Attorney-in-fact for Lisa Y. Foo	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)